Price to Earning breakdown for AP PharmaPrice to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investor monitor on a daily basis. Holding a low PE stock is less risky because. When a company's profitability fall, it is likely that earnings will also go down..In other words, if you start from a lower position your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.Compare AP Pharma to competition
AP Pharma Price to Earning Assessment
Based on latest financial disclosure the price to earning indicator of AP Pharma Inc is roughly 12.48 times. This is 84.37% lower than that of Healthcare sector, and 67.82% lower than that of Drug Manufacturers - Major industry, The Price to Earning for all stocks is 47.85% higher than the company.
Filter other Stocks by Price to Earning
Price to Earning ComparisonAP Pharma is currently under evaluation in price to earning category among related companies.
Follow AP Pharma Price to Earning with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Other AP Pharma Fundamentals